SAM
KITE

Shell Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Shell Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,104
Closed -$1.1M – 1137
2017
Q3 		$1.1M Hold
6,104
– – 0.02% 573
2017
Q2 		$633K Buy
+6,104
New +$498K 0.01% 825

Shell Asset Management's KITE Position: Q4 2017 in Review

Shell Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 6,104 shares — an estimated $1.1M sold.

Shell Asset Management first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $1.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Shell Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Shell Asset Management sold 6,104 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.1M.
  • Shell Asset Management first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
  • Shell Asset Management's Kite Pharma, Inc. position peaked at $1.1M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Shell Asset Management's 13F filing for Q4 2017, filed 9 Feb 2018.